These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6297013)

  • 1. [Cutaneous lesions in human African trypanosomiasis].
    Tatibouet MH; Gentilini M; Brucker G
    Sem Hop; 1982 Nov; 58(40):2318-24. PubMed ID: 6297013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
    Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
    Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin features accompanying imported human African trypanosomiasis: hemolymphatic Trypanosoma gambiense infection among two French expatriates with dermatologic manifestations.
    Ezzedine K; Darie H; Le Bras M; Malvy D
    J Travel Med; 2007; 14(3):192-6. PubMed ID: 17437477
    [No Abstract]   [Full Text] [Related]  

  • 4. [Human African trypanosomiasis from Trypanosoma brucei gambiense with inoculation chancre in a French expatriate].
    Malvy D; Djossou F; Weill FX; Chapuis P; Longy-Boursier M; Le Bras M
    Med Trop (Mars); 2001; 61(4-5):323-7. PubMed ID: 11803822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous manifestations of African trypanosomiasis.
    McGovern TW; Williams W; Fitzpatrick JE; Cetron MS; Hepburn BC; Gentry RH
    Arch Dermatol; 1995 Oct; 131(10):1178-82. PubMed ID: 7574836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
    Gehrig S; Efferth T
    Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Three patients with African sleeping sickness following a visit to Tanzania].
    Mendonça Melo M; Rasica M; van Thiel PP; Richter C; Kager PA; Wismans PJ
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2552-6. PubMed ID: 12532670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep structure: a new diagnostic tool for stage determination in sleeping sickness.
    Buguet A; Bisser S; Josenando T; Chapotot F; Cespuglio R
    Acta Trop; 2005 Jan; 93(1):107-17. PubMed ID: 15589803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Melarsoprol].
    Simon F
    Med Trop (Mars); 1999; 59(4):331-2. PubMed ID: 10816741
    [No Abstract]   [Full Text] [Related]  

  • 10. A returning traveller with fever, facial swelling, and skin lesions.
    Richter J; Göbels S; Göbel T; Westenfeld R; Müller-Stöver I; Häussinger D
    BMJ; 2012 Mar; 344():e2092. PubMed ID: 22442353
    [No Abstract]   [Full Text] [Related]  

  • 11. Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy.
    Checkley AM; Pepin J; Gibson WC; Taylor MN; Jäger HR; Mabey DC
    Trans R Soc Trop Med Hyg; 2007 May; 101(5):523-6. PubMed ID: 17270227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of three regimens of melarsoprol in the treatment of Trypanosoma brucei gambiense trypanosomiasis.
    Pépin J; Mpia B
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):437-41. PubMed ID: 16483622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Double trypanosomal chancre revealing West African trypanosomiasis in a Frenchman living in Gabon].
    Hope-Rapp E; Moussa Coulibaly O; Klement E; Danis M; Bricaire F; Caumes E
    Ann Dermatol Venereol; 2009 Apr; 136(4):341-5. PubMed ID: 19361701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.
    Balasegaram M; Young H; Chappuis F; Priotto G; Raguenaud ME; Checchi F
    Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):280-90. PubMed ID: 18947846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
    Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
    Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda].
    Legros D; Fournier C; Gastellu Etchegorry M; Maiso F; Szumilin E
    Bull Soc Pathol Exot; 1999 Jul; 92(3):171-2. PubMed ID: 10472443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, controlled trial of treatments for second-stage sleeping sickness.
    Woodrow CJ; Abel PM; Krishna S
    J Infect Dis; 2007 Aug; 196(4):650-1. PubMed ID: 17624857
    [No Abstract]   [Full Text] [Related]  

  • 19. Human African trypanosomiasis with 7-year incubation period: clinical, laboratory and neuroimaging findings.
    Wengert O; Kopp M; Siebert E; Stenzel W; Hegasy G; Suttorp N; Stich A; Zoller T
    Parasitol Int; 2014 Jun; 63(3):557-60. PubMed ID: 24613272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
    Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P
    J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.